Security key
00847L100
- Security type / class
- Equity / COM
- Total 13F shares
- 23,075,157
- Total 13F value
- $86,523,961
- Share change
- +118,777
- SEC-reported price per share
- $3.75
- Number of holders
- 44
- Value change
- +$651,287
- Number of buys
- 19
- Number of sells
- 33
Report period
Q2 2017
Institutions
44
Top holders
10
AGRX full security history
Ownership snapshot
Full 13F holder table
AGILE THERAPEUTICS INC SEC filings
AGILE THERAPEUTICS INC company facts
Broader feeds
Ownership snapshot
Top reported holders of AGRX - AGILE THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ProQuest Associates IV LLC
Disclosed value leader
ProQuest Associates IV LLC
Comparable rows
0/15
Latest evidence
31 Mar 2017
13F
Highest disclosed value: $16,250,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ProQuest Associates IV LLC has the largest disclosed position value at $16.25M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ProQuest Associates IV LLC's linked filing trail.
Disclosed position value
Top 5
ProQuest Associates IV LLC
$16.25M
INVESTOR AB
$11.27M
FRANKLIN TEMPLETON INC
$6.38M
Aisling Capital LLC
$5.78M
CAXTON CORP
$5.2M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ProQuest Associates IV LLC |
13F
Company
|
—
denominator unverified
|
$16,250,000
5,062,363 shares
|
— | 31 Mar 2017 |
| INVESTOR AB |
13F
Company
|
—
denominator unverified
|
$11,268,000
3,510,189 shares
|
— | 31 Mar 2017 |
| FRANKLIN TEMPLETON INC |
13F
Company
|
—
denominator unverified
|
$6,383,000
1,991,622 shares
|
— | 31 Mar 2017 |
| Aisling Capital LLC |
13F
Company
|
—
denominator unverified
|
$5,776,000
1,804,933 shares
|
— | 31 Mar 2017 |
| CAXTON CORP |
13F
Company
|
—
denominator unverified
|
$5,204,000
1,623,567 shares
|
— | 31 Mar 2017 |
| Vivo Capital, LLC |
13F
Company
|
—
denominator unverified
|
$4,852,000
1,513,975 shares
|
— | 31 Mar 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
44
Shares
23,075,157
Rows available
44
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
52
Q2 2017 holders
44
Holder diff
-8
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 value | Q2 2017 value | Value change | Value Chg % |
|---|